HCPCS Code Descriptor:
Leuprolide acetate, per 1 mg
72664-0611-28, 70121-2537-06, 55150-0478-01, 47335-0936-40, 00781-4003-32
Route of Administration:
LEUPROLIDE ACETATE is an Oncology drug manufactured by Vgyaan Pharmaceuticals and administered via the Subcutaneous route of administration. The J Code: J9218 is aligned to the drug LEUPROLIDE ACETATE.
Leuprolide Acetate is categorized as a gonadotropin-releasing hormone agonist. It works by reducing the number of certain hormones in the patient’s body. Leuprolide acetate can help manage the symptoms of certain cancers and help treat certain hormone disorders. This medication is administered via intramuscular injection by a doctor or another healthcare professional. Leuprolide Acetate (J9218) is a generic drug that is manufactured by Sandoz, Sun Pharma, AuroMedics, Amneal Pharmaceuticals, Vgyaan Pharmaceuticals, and others. There are many patient assist programs for this Leuprolide Acetate. Tolmar, Abbvie, and others offer patient support websites.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Leuprolide acetate injeciton
Billing and Coding Guide: